Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. - Wikidata - wikimedia - TriplyDB

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

http://www.wikidata.org/entity/Q37101017

about

Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target Imaging mass spectrometry of intact proteins from alcohol-preserved tissue specimens: bypassing formalin fixation.Mast cells mediate malignant pleural effusion formation.Development of a rabbit pleural cancer model by using VX2 tumors.Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.[Establishment of a malignant pleural effusion mouse model with Lewis lung carcinoma cell lines expressing enhanced green fluorescent protein].Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.Multivariate modelling with (1)H NMR of pleural effusion in murine cerebral malaria Pleural involvement in lung cancer.Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.Visualization of Fra-1/AP-1 activation during LPS-induced inflammatory lung injury using fluorescence optical imaging.A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis.Bioluminescence imaging.The angiopoietin/Tie2 axis mediates malignant pleural effusion formation Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.Translational advances in pleural malignancies.Malignant pleural effusion: tumor-host interactions unleashed.The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.Switching off malignant pleural effusion formation-fantasy or future?Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent.Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.Protective effects of mastic oil from Pistacia lentiscus variation chia against experimental growth of lewis lung carcinoma.A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.Zoledronic acid is effective against experimental malignant pleural effusion.Beneficial actions of the anti-inflammatory dimethyl fumarate in glioblastomas Establishment of a malignant pleural effusion mouse model with lewis lung carcinoma cell lines expressing enhanced green fluorescent protein.Establishment of a malignant pleural effusion mouse model: pathogenesis pathways.Monoclonal antibody targeting of mononuclear cell chemokines driving malignant pleural effusion.Malignant pleural effusion: further translational research is crucial.Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic aetiology.Malignant pleural effusions: fixing the leaky faucet.

P2860

Q28475474-8FC9A8E9-D88B-46FD-9BF7-A2A8D5D785FC Q28611413-4F0445BA-EB91-49CA-BB17-8E52AF404337 Q30479892-C30E4C5F-7218-4F21-8088-4E8DA408D0EC Q30657333-3562033C-7595-467D-B6D2-F16CF73BFA22 Q33347764-6668244A-E09E-4D14-A17C-86809839B3EB Q33737084-925AF55C-5647-46FB-A8F0-511A55ABBFD3 Q33925776-E2F6266C-A5F8-47F0-BD27-B9020EED4413 Q34297841-910D95B1-BF67-4033-B614-EE529B50C920 Q34402445-0E1D3770-FC8C-44BD-B43F-AE20FC3071DB Q34535252-4C37A538-8760-4F2B-ACF8-FE71A7533FE9 Q34963525-8E79D8E6-AF05-4DC2-AA3B-B1B3FB8164EF Q35005521-213E8AAB-2F4E-4557-9E40-5A6FAAF75902 Q35586924-0401C61F-2906-4B41-B0A4-BA66C6CDADD7 Q35739559-52AFD5B3-3365-4C49-8F67-72836F04A184 Q35883572-19F4BABF-6B84-41A0-98FB-825E6433C7CD Q35959840-EF3A91AC-26BE-4D6F-B69B-DC2A409BB73E Q36066547-EF6F3281-8776-47B6-920F-AE84F07576C3 Q36276848-9E6CEC39-E65B-4C14-9889-9A9072B94FA1 Q36341235-4825AE22-74B8-4B68-BD7D-145BF0089068 Q37109566-615BCDE3-9F38-4D47-AA64-174EC4C3E9BF Q37190280-5380316D-9121-4360-972C-A2C13A544B3E Q37806309-EEB9D15B-3F3D-4041-B37E-FF35ABBA3AAF Q38015001-7E24F098-941D-4C5B-A416-F6E87FE31216 Q38058513-20D717E8-E81F-44C3-9581-4F9A07399240 Q38543525-09616025-91F4-4435-8C0E-E34B09E25157 Q38585167-DBE6989E-DBF9-4E8F-A0C1-BDE54C43DBD6 Q38803126-9457D5A2-112E-4705-A5EC-F94E624E4894 Q38846141-6C30F177-6B0A-4135-8CF4-DB4593A516B2 Q38938729-1D40A4D0-8681-4D24-BAAA-0A4BBF68FC6B Q39389185-C37C56FE-24BA-4BD4-A73E-75FC7553E3EB Q39786074-EDE80123-A3CD-4658-B4B6-0E0EB24ADD15 Q39931549-4A715E0A-D72B-4FE6-8FB3-58FC8A10FD78 Q39995123-C9058E94-8F69-45F5-A9BB-81154C9AEF7E Q41855478-D9151888-B586-4A3D-B3CD-A014A37320E5 Q41978764-EB9FC4AB-60F8-4ADE-A010-073D49F83D0F Q42220280-95CCAF79-3899-49FD-82FA-B3F87E6689A4 Q42745376-7C752284-6059-42F8-9C1F-6435E8F79013 Q43195730-9E3BB08D-9CAC-443F-AD25-1131B5168727 Q46343723-CCD10087-9A76-4A92-B474-5937B84EB939 Q46530300-57D3DBBB-786D-4012-B9A4-E6DB55F4443A

P2860

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

http://www.wikidata.org/entity/Q37101017

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 October 2005

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@en

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@nl

type

label

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@en

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@nl

prefLabel

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@en

Nuclear factor-kappaB affects ...... of malignant pleural effusion.

@nl

P1433

Q37101017-75873A6A-61FD-49C3-AEE9-DED9AA70D8EE

P1476

Q37101017-E6549456-2821-48FC-B174-8E73D43213C4

P2093

Q37101017-002771EF-3396-4127-9A4F-7D9F91AA8CBB

Q37101017-2BA55742-20D3-4245-97CC-39749921631D

Q37101017-616EB565-5AAE-4A92-ABFF-8B4C3FBC9E8D

Q37101017-6F21FBA0-76C5-429B-8620-ECE132CE475F

Q37101017-96F445E4-C72E-409A-8B24-A1CF0E1378D1

Q37101017-A0FC4556-5721-4542-8BA5-3ECCA0DD6A13

Q37101017-A32C7089-AC4B-4F8A-B1C7-D96603EEFD66

Q37101017-C89E249A-53EA-439B-A00B-9E170C9F5D06

Q37101017-DD961FA4-470F-402D-9F33-BAD84184539F

P2860

Q37101017-01991E78-C760-45AC-BD4A-434D7F6F3823

Q37101017-03FA3B87-B405-44E7-A576-8AA5876CE36C

Q37101017-051DC3BA-E8DC-4CCB-9B99-CE60242F2F4C

Q37101017-06D9FEB1-14EF-4C35-AC37-6918017C2914

Q37101017-0CD2AC40-357F-4497-8A1E-7A366E953470

Q37101017-0F080E5C-1C0B-4C20-9186-56ED20CF9464

Q37101017-121E063B-E9E3-4B47-A7F0-8F6AED4B86F7

Q37101017-18714F77-73A2-4CA8-87B0-182D28CCA1ED

Q37101017-1A325301-F41A-4ED8-898A-BBB3A1533F76

Q37101017-1C136323-A7DF-474C-88F6-E22DB9D8923F

P304

Q37101017-0A50CC24-93DE-4389-9881-82AF731DD7F5

P31

Q37101017-C7B43093-E36D-4485-A913-79A3322F4D86

P356

Q37101017-CC04E16C-3E93-49E9-A091-0330A56BBA20

P433

Q37101017-4E2ECAFE-5261-49A2-A080-757624938391

P478

Q37101017-7C6A5A6B-9EDF-42E6-A47E-69047128706C

P50

Q37101017-12E2D3FD-5466-479A-B2F0-316DE62F5E60

Q37101017-27E9BBEC-7AE2-46F0-9685-39A7E95562F4

P577

Q37101017-31BC1622-5D1C-4815-9A9C-A16AF0EA6BE3

P698

Q37101017-0F52F223-7118-4410-B5C0-BAB867CDFEDD

P932

Q37101017-7344BA0B-4997-4EBC-8763-9427D8B77367

P356

RCMB.2005-0130OC

P1433

American Journal of Respiratory Cell and Molecular Biology

P1476

Nuclear factor-kappaB affects ...... of malignant pleural effusion

@en

P2093

Daphne Mitchell

http://www.w3.org/2001/XMLSchema#string

Fiona E Yull

http://www.w3.org/2001/XMLSchema#string

Ioannis Kalomenidis

http://www.w3.org/2001/XMLSchema#string

M Brett Everhart

http://www.w3.org/2001/XMLSchema#string

Richard W Light

http://www.w3.org/2001/XMLSchema#string

Semra Bilaceroglu

http://www.w3.org/2001/XMLSchema#string

Timothy S Blackwell

http://www.w3.org/2001/XMLSchema#string

William E Lawson

http://www.w3.org/2001/XMLSchema#string

Zhiwen Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Management of malignant pleural effusions.

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

Advances in in vivo bioluminescence imaging of gene expression.

Update on non-acquired immunodeficiency syndrome-defining malignancies.

Scaling down imaging: molecular mapping of cancer in mice.

Nuclear factor-kappa B and cancer: its role in prevention and therapy.

P304

142-150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1165/RCMB.2005-0130OC

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Georgios T. Stathopoulos

Todd E. Peterson

P577

2005-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16210694

http://www.w3.org/2001/XMLSchema#string

P932

2644178

http://www.w3.org/2001/XMLSchema#string